Abstract
Due to their small size and red-shifted excitation and emission bands, lead sulfide (PbS) near-infrared (NIR) quantum dots (QDs) are potentially promising optical contrast agents for in vivo tumor imaging applications. In this phantom-based study, we correlated PbS NIR QD concentrations to feasible imaging depths. A fluorescence imaging system (FIS) was used to acquire images of QDfilled tumor models, which were embedded in liquid tissue phantoms. For the lowest tested concentration of 200 nM, PbS-QD-filled tumor models could be imaged at a tissue phantom depth of 15 mm. Additionally, the FIS was used to compare the imaging potential of PbS QDs to quantum dots that fluoresce in the visible spectral range. Results indicated that tumor models with photons emitted in the NIR region can be imaged with less distortion than those with photons emitted in the visible spectrum. As the phantom thickness over the tumors was increased from 0 to 1.75 mm, the half-intensity widths of normalized fluorescence images produced by red QDs (acquired peak at ∼645 nm) increased by ∼300%; for NIR QDs (acquired peak at ~880 nm), the widths increased by ∼140%. Due to the decreased scattering effect of the tissue phantoms in the NIR spectral range, the margins of PbS QD images were better defined than those of the corresponding red images.
Keywords: Near-infrared, quantum dot, fluorescence, optical imaging, phantom
Current Nanoscience
Title: Near-Infrared Quantum Dot Contrast Agents for Fluorescence Tissue Imaging: A Phantom Study
Volume: 5 Issue: 2
Author(s): Jiantang Sun, Kun Fu, Ming-Qiang Zhu, Lissett Bickford, Eric Post and Rebekah Drezek
Affiliation:
Keywords: Near-infrared, quantum dot, fluorescence, optical imaging, phantom
Abstract: Due to their small size and red-shifted excitation and emission bands, lead sulfide (PbS) near-infrared (NIR) quantum dots (QDs) are potentially promising optical contrast agents for in vivo tumor imaging applications. In this phantom-based study, we correlated PbS NIR QD concentrations to feasible imaging depths. A fluorescence imaging system (FIS) was used to acquire images of QDfilled tumor models, which were embedded in liquid tissue phantoms. For the lowest tested concentration of 200 nM, PbS-QD-filled tumor models could be imaged at a tissue phantom depth of 15 mm. Additionally, the FIS was used to compare the imaging potential of PbS QDs to quantum dots that fluoresce in the visible spectral range. Results indicated that tumor models with photons emitted in the NIR region can be imaged with less distortion than those with photons emitted in the visible spectrum. As the phantom thickness over the tumors was increased from 0 to 1.75 mm, the half-intensity widths of normalized fluorescence images produced by red QDs (acquired peak at ∼645 nm) increased by ∼300%; for NIR QDs (acquired peak at ~880 nm), the widths increased by ∼140%. Due to the decreased scattering effect of the tissue phantoms in the NIR spectral range, the margins of PbS QD images were better defined than those of the corresponding red images.
Export Options
About this article
Cite this article as:
Sun Jiantang, Fu Kun, Zhu Ming-Qiang, Bickford Lissett, Post Eric and Drezek Rebekah, Near-Infrared Quantum Dot Contrast Agents for Fluorescence Tissue Imaging: A Phantom Study, Current Nanoscience 2009; 5 (2) . https://dx.doi.org/10.2174/157341309788185433
DOI https://dx.doi.org/10.2174/157341309788185433 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance
Current Molecular Pharmacology Does Hypoxic Response Mediate Primary Resistance to Sunitinib in Untreated Locally Advanced Breast Cancer?
Current Cancer Drug Targets Dendrimers: Nanosized Multifunctional Platform for Drug Delivery
Drug Delivery Letters Identification of a Good-Prognosis IDH-Mutant-Like Population of Patients with Diffuse Gliomas
Current Molecular Medicine The Significance of Transferrin Receptors in Oncology: the Development of Functional Nano-based Drug Delivery Systems
Current Drug Delivery Blind Snipers: Relevant Off Target Effects of Non-chemotherapeutic Agents in Oncology: Review of the Literature
Reviews on Recent Clinical Trials Nucleic Acid Carrier Systems Based on Polyethylenimine Conjugates for the Treatment of Metastatic Tumors
Current Medicinal Chemistry Hypoxic Radiosensitizers and Hypoxic Cytotoxins in Radiation Oncology
Current Medicinal Chemistry - Anti-Cancer Agents A Review of the ADAMTS Family, Pharmaceutical Targets of the Future
Current Pharmaceutical Design Cannabinoids and Cancer
Mini-Reviews in Medicinal Chemistry Individualized Treatment Planning in Oncology: Role of PET and Radiolabelled Anticancer Drugs in Predicting Tumour Resistance
Current Pharmaceutical Design Imaging Findings of Primary Non-functioning Hepatic Paraganglioma: A Case Report
Current Medical Imaging Imaging in the Age of Molecular Medicine: Monitoring of Anti-Angiogenic Treatments
Current Pharmaceutical Biotechnology DNMT Inhibitors in Cancer, Current Treatments and Future Promising Approach: Inhibition of Specific DNMT-Including Complexes
Epigenetic Diagnosis & Therapy (Discontinued) Molecular Biology of Nucleoside Transporters and their Distributions and Functions in the Brain
Current Topics in Medicinal Chemistry A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity
Current Drug Targets The Accomplices of NF-κB Lead to Radioresistance
Current Protein & Peptide Science Human Sirtuins: An Overview of an Emerging Drug Target in Age-Related Diseases and Cancer
Current Drug Targets Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Novel Strategies in Cancer Therapeutics: Targeting Enzymes Involved in Cell Cycle Regulation and Cellular Proliferation
Current Cancer Drug Targets